[Federal Register Volume 65, Number 231 (Thursday, November 30, 2000)]
[Notices]
[Pages 71327-71328]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-30464]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director; Recombinant DNA Advisory Committee 
Meeting; Safety Symposium on Gene Transfer Research

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee (RAC) and a Safety Symposium on 
Gene Transfer Research.
    The RAC meeting will be held from 8 a.m. to 5 p.m. on December 13 
and 15, 2000 at the National Institutes of Health (NIH), Building 31, C 
Wing, Conference Room 10, 9000 Rockville Pike, Bethesda, MD 20892. The 
Committee will review changes to the process for submission and review 
of gene transfer research protocols; selected human gene transfer 
protocols; NIH policy on serious adverse event reporting; data 
management activities related to human gene transfer clinical trials; 
and other matters to be considered by the Committee.
    The Safety Symposium on Gene Transfer Research will be held from 8 
a.m. to 5 p.m. on December 14, 2000 at the NIH Natcher Auditorium, 9000 
Rockville Pike, Bethesda, MD 20892. The symposium will explore safety 
considerations in gene transfer clinical research in cardiovascular 
diseases.
    Both meetings are open to the public with attendance limited to 
space available. Draft meeting agendas and other information will be 
posted at the Office of Biotechnology Activities' website: http://www.nih.gov/od/oba.
    Individuals who wish to provide public comments or who plan to 
attend the meeting and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify Kelly 
Fennington, Program Analyst, Office of

[[Page 71328]]

Biotechnology Activities by telephone at 301-496-9838 or E-mail at 
<a href="/cdn-cgi/l/email-protection#56103338383f38311d16393278383f3e78313920"><span class="__cf_email__" data-cfemail="0c4a69626265626b474c636822626564226b637a">[email protected]</span></a>
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
virtually every NIH and Federal research program in which DNA 
recombinant molecule techniques could be used, it has been determined 
not to be cost effective or in the public interest to attempt to list 
these programs. Such a list would likely require several additional 
pages. In addition, NIH could not be certain that every Federal program 
would be included as many Federal agencies, as well as private 
organizations, both national and international, have elected to follow 
the NIH Guidelines. In lieu of the individual program listing, NIH 
invites readers to direct questions to the information address above 
about whether individual programs listed in the Catalog of Federal 
Domestic Assistance are affected.

    Dated: November 21, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-30464 Filed 11-30-00; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>